rog-202203310000084748December 312022Q1falseP1Y.005http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent0.0 million0.0 million0.0 million00000847482022-01-012022-03-3100000847482022-04-25xbrli:sharesiso4217:USD00000847482021-01-012021-03-31iso4217:USDxbrli:shares00000847482022-03-3100000847482021-12-3100000847482020-12-3100000847482021-03-310000084748us-gaap:CommonStockMember2021-12-310000084748us-gaap:CommonStockMember2020-12-310000084748us-gaap:CommonStockMember2022-01-012022-03-310000084748us-gaap:CommonStockMember2021-01-012021-03-310000084748us-gaap:CommonStockMember2022-03-310000084748us-gaap:CommonStockMember2021-03-310000084748us-gaap:AdditionalPaidInCapitalMember2021-12-310000084748us-gaap:AdditionalPaidInCapitalMember2020-12-310000084748us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000084748us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000084748us-gaap:AdditionalPaidInCapitalMember2022-03-310000084748us-gaap:AdditionalPaidInCapitalMember2021-03-310000084748us-gaap:RetainedEarningsMember2021-12-310000084748us-gaap:RetainedEarningsMember2020-12-310000084748us-gaap:RetainedEarningsMember2022-01-012022-03-310000084748us-gaap:RetainedEarningsMember2021-01-012021-03-310000084748us-gaap:RetainedEarningsMember2022-03-310000084748us-gaap:RetainedEarningsMember2021-03-310000084748us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000084748us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000084748us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000084748us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000084748us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000084748us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000084748us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310000084748us-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000084748us-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310000084748us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748rog:CopperDerivativeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748rog:CopperDerivativeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748rog:CopperDerivativeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310000084748rog:CopperDerivativeContractMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000084748us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000084748us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748rog:CopperDerivativeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748rog:CopperDerivativeContractMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748rog:CopperDerivativeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000084748rog:CopperDerivativeContractMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000084748rog:USDCNHNotionalAmountForeignCurrencyDerivativeMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-03-310000084748rog:EURUSDNotionalAmountForeignCurrencyDerivativeMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-03-31iso4217:EUR0000084748us-gaap:NondesignatedMemberrog:KRWUSDNotionalAmountofForeignCurrencyDerivativeMemberus-gaap:ForeignExchangeForwardMember2022-03-31iso4217:KRW0000084748rog:BankTermLoanMember2022-03-31rog:contract0000084748rog:CopperPeriodOneMemberus-gaap:NondesignatedMember2022-03-31rog:tons_per_month0000084748us-gaap:NondesignatedMemberrog:CopperPeriodTwoMember2022-03-310000084748us-gaap:NondesignatedMemberrog:CopperPeriodThreeMember2022-03-310000084748us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2022-01-012022-03-310000084748us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherOperatingIncomeExpenseMember2021-01-012021-03-310000084748us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:OtherOperatingIncomeExpenseMember2022-01-012022-03-310000084748us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:OtherOperatingIncomeExpenseMember2021-01-012021-03-310000084748us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000084748us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000084748us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310000084748us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-03-310000084748us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000084748us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310000084748us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000084748us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310000084748us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-03-310000084748us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-03-310000084748us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310000084748us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-310000084748rog:AdvancedElectronicsSolutionsMember2021-12-310000084748rog:ElastomericMaterialSolutionsMember2021-12-310000084748us-gaap:AllOtherSegmentsMember2021-12-310000084748rog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748rog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748us-gaap:AllOtherSegmentsMember2022-01-012022-03-310000084748rog:AdvancedElectronicsSolutionsMember2022-03-310000084748rog:ElastomericMaterialSolutionsMember2022-03-310000084748us-gaap:AllOtherSegmentsMember2022-03-310000084748us-gaap:CustomerRelationshipsMember2022-03-310000084748us-gaap:CustomerRelationshipsMember2021-12-310000084748us-gaap:DevelopedTechnologyRightsMember2022-03-310000084748us-gaap:DevelopedTechnologyRightsMember2021-12-310000084748us-gaap:TrademarksAndTradeNamesMember2022-03-310000084748us-gaap:TrademarksAndTradeNamesMember2021-12-310000084748us-gaap:NoncompeteAgreementsMember2022-03-310000084748us-gaap:NoncompeteAgreementsMember2021-12-310000084748us-gaap:CustomerRelationshipsMember2022-01-012022-03-310000084748us-gaap:DevelopedTechnologyRightsMember2022-01-012022-03-310000084748us-gaap:TrademarksAndTradeNamesMember2022-01-012022-03-310000084748us-gaap:NoncompeteAgreementsMember2022-01-012022-03-310000084748us-gaap:PerformanceSharesMember2022-01-012022-03-310000084748srt:MinimumMemberus-gaap:PerformanceSharesMember2022-01-012022-03-31xbrli:pure0000084748srt:MaximumMemberus-gaap:PerformanceSharesMember2022-01-012022-03-310000084748us-gaap:PerformanceSharesMember2021-02-102021-02-100000084748us-gaap:PerformanceSharesMember2021-12-310000084748us-gaap:PerformanceSharesMember2022-03-310000084748us-gaap:PerformanceSharesMember2021-01-012021-03-310000084748rog:TimeBasedRestrictedStockMember2022-01-012022-03-310000084748rog:TimeBasedRestrictedStockMember2021-12-310000084748rog:TimeBasedRestrictedStockMember2022-03-310000084748rog:TimeBasedRestrictedStockMember2021-01-012021-03-310000084748srt:ChiefExecutiveOfficerMember2021-02-102021-11-090000084748rog:DeferredStockUnitsMember2022-01-012022-03-310000084748rog:DeferredStockUnitsMember2021-12-310000084748rog:DeferredStockUnitsMember2022-03-310000084748rog:DeferredStockUnitsMember2021-01-012021-03-310000084748us-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-160000084748us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-162020-10-160000084748rog:EuroDenominatedBankLoansMemberus-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-160000084748rog:SterlingOvernightIndexAverageSONIAMemberus-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-162020-10-160000084748rog:RFRBankLoansMemberus-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-160000084748us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2021-01-012021-12-310000084748srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-162020-10-160000084748srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-162020-10-160000084748us-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-162020-10-160000084748us-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2022-03-310000084748us-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2021-01-012021-03-310000084748us-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2022-01-012022-03-310000084748rog:ThirdAmendedCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-01-012022-03-310000084748rog:ThirdAmendedCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2021-01-012021-03-310000084748us-gaap:RevolvingCreditFacilityMember2022-03-310000084748us-gaap:RevolvingCreditFacilityMember2021-12-310000084748rog:FederalFundsRateMemberus-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2020-10-162020-10-1600000847482021-06-302021-06-300000084748us-gaap:SubsequentEventMember2022-04-012022-04-30rog:plan0000084748rog:MergedPlanMemberus-gaap:PensionPlansDefinedBenefitMember2019-10-170000084748us-gaap:AssetHeldInTrustMemberrog:RogersEmployeeSavingsandInvestmentPlanRESIPMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310000084748us-gaap:AssetHeldInTrustMemberrog:RogersEmployeeSavingsandInvestmentPlanRESIPMemberus-gaap:PensionPlansDefinedBenefitMember2020-07-300000084748us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-03-310000084748us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310000084748us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-03-310000084748us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-03-310000084748rog:MergedPlanMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310000084748rog:UnionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-03-310000084748rog:UnionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-03-310000084748rog:ConnecticutVoluntaryCorrectiveActionProgramMember2022-01-012022-03-310000084748rog:ConnecticutVoluntaryCorrectiveActionProgramMember2022-03-31rog:claim0000084748us-gaap:TransferredOverTimeMemberrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748us-gaap:TransferredOverTimeMemberrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748us-gaap:AllOtherSegmentsMemberus-gaap:TransferredOverTimeMember2022-01-012022-03-310000084748us-gaap:TransferredOverTimeMember2022-01-012022-03-310000084748us-gaap:TransferredAtPointInTimeMemberrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748us-gaap:TransferredAtPointInTimeMemberrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748us-gaap:TransferredAtPointInTimeMemberus-gaap:AllOtherSegmentsMember2022-01-012022-03-310000084748us-gaap:TransferredAtPointInTimeMember2022-01-012022-03-310000084748us-gaap:TransferredOverTimeMemberrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748us-gaap:TransferredOverTimeMemberrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748us-gaap:AllOtherSegmentsMemberus-gaap:TransferredOverTimeMember2021-01-012021-03-310000084748us-gaap:TransferredOverTimeMember2021-01-012021-03-310000084748us-gaap:TransferredAtPointInTimeMemberrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748us-gaap:TransferredAtPointInTimeMemberrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748us-gaap:TransferredAtPointInTimeMemberus-gaap:AllOtherSegmentsMember2021-01-012021-03-310000084748us-gaap:TransferredAtPointInTimeMember2021-01-012021-03-310000084748rog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748rog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748us-gaap:AllOtherSegmentsMember2021-01-012021-03-310000084748country:USrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748country:USrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748country:USus-gaap:AllOtherSegmentsMember2022-01-012022-03-310000084748country:US2022-01-012022-03-310000084748rog:OtherAmericasMemberrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748rog:OtherAmericasMemberrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748rog:OtherAmericasMemberus-gaap:AllOtherSegmentsMember2022-01-012022-03-310000084748rog:OtherAmericasMember2022-01-012022-03-310000084748srt:AmericasMemberrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748srt:AmericasMemberrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748us-gaap:AllOtherSegmentsMembersrt:AmericasMember2022-01-012022-03-310000084748srt:AmericasMember2022-01-012022-03-310000084748country:CNrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748country:CNrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748country:CNus-gaap:AllOtherSegmentsMember2022-01-012022-03-310000084748country:CN2022-01-012022-03-310000084748rog:OtherAsiaPacificMemberrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748rog:OtherAsiaPacificMemberrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748us-gaap:AllOtherSegmentsMemberrog:OtherAsiaPacificMember2022-01-012022-03-310000084748rog:OtherAsiaPacificMember2022-01-012022-03-310000084748srt:AsiaPacificMemberrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748srt:AsiaPacificMemberrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748srt:AsiaPacificMemberus-gaap:AllOtherSegmentsMember2022-01-012022-03-310000084748srt:AsiaPacificMember2022-01-012022-03-310000084748country:DErog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748country:DErog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748us-gaap:AllOtherSegmentsMembercountry:DE2022-01-012022-03-310000084748country:DE2022-01-012022-03-310000084748rog:OtherEMEAMemberrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748rog:OtherEMEAMemberrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748us-gaap:AllOtherSegmentsMemberrog:OtherEMEAMember2022-01-012022-03-310000084748rog:OtherEMEAMember2022-01-012022-03-310000084748us-gaap:EMEAMemberrog:AdvancedElectronicsSolutionsMember2022-01-012022-03-310000084748us-gaap:EMEAMemberrog:ElastomericMaterialSolutionsMember2022-01-012022-03-310000084748us-gaap:AllOtherSegmentsMemberus-gaap:EMEAMember2022-01-012022-03-310000084748us-gaap:EMEAMember2022-01-012022-03-310000084748country:USrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748country:USrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748country:USus-gaap:AllOtherSegmentsMember2021-01-012021-03-310000084748country:US2021-01-012021-03-310000084748rog:OtherAmericasMemberrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748rog:OtherAmericasMemberrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748rog:OtherAmericasMemberus-gaap:AllOtherSegmentsMember2021-01-012021-03-310000084748rog:OtherAmericasMember2021-01-012021-03-310000084748srt:AmericasMemberrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748srt:AmericasMemberrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748us-gaap:AllOtherSegmentsMembersrt:AmericasMember2021-01-012021-03-310000084748srt:AmericasMember2021-01-012021-03-310000084748country:CNrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748country:CNrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748country:CNus-gaap:AllOtherSegmentsMember2021-01-012021-03-310000084748country:CN2021-01-012021-03-310000084748rog:OtherAsiaPacificMemberrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748rog:OtherAsiaPacificMemberrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748us-gaap:AllOtherSegmentsMemberrog:OtherAsiaPacificMember2021-01-012021-03-310000084748rog:OtherAsiaPacificMember2021-01-012021-03-310000084748srt:AsiaPacificMemberrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748srt:AsiaPacificMemberrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748srt:AsiaPacificMemberus-gaap:AllOtherSegmentsMember2021-01-012021-03-310000084748srt:AsiaPacificMember2021-01-012021-03-310000084748country:DErog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748country:DErog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748us-gaap:AllOtherSegmentsMembercountry:DE2021-01-012021-03-310000084748country:DE2021-01-012021-03-310000084748rog:OtherEMEAMemberrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748rog:OtherEMEAMemberrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748us-gaap:AllOtherSegmentsMemberrog:OtherEMEAMember2021-01-012021-03-310000084748rog:OtherEMEAMember2021-01-012021-03-310000084748us-gaap:EMEAMemberrog:AdvancedElectronicsSolutionsMember2021-01-012021-03-310000084748us-gaap:EMEAMemberrog:ElastomericMaterialSolutionsMember2021-01-012021-03-310000084748us-gaap:AllOtherSegmentsMemberus-gaap:EMEAMember2021-01-012021-03-310000084748us-gaap:EMEAMember2021-01-012021-03-310000084748rog:ManufacturingFootprintOptimizationMember2022-01-012022-03-310000084748rog:ManufacturingFootprintOptimizationMember2021-01-012021-03-310000084748us-gaap:EmployeeSeveranceMember2021-12-310000084748us-gaap:EmployeeSeveranceMember2022-01-012022-03-310000084748us-gaap:EmployeeSeveranceMember2022-03-310000084748us-gaap:FireMember2021-01-012021-03-310000084748rog:SiliconeEngineeringLtdMember2021-10-082021-10-080000084748rog:SiliconeEngineeringLtdMember2021-10-080000084748rog:SiliconeEngineeringLtdMemberus-gaap:SubsequentEventMember2022-04-300000084748us-gaap:RevolvingCreditFacilityMemberrog:FourthAmendedAndRestatedCreditAgreementMember2021-10-080000084748rog:SiliconeEngineeringLtdMember2021-01-012021-03-310000084748rog:RogersCorporationMemberrog:DuPontDeNemoursIncMember2021-11-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________
FORM 10-Q
_______________________________
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2022
or
| | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _______________ to _______________
Commission file number 1-4347
_______________________________
ROGERS CORPORATION
(Exact Name of Registrant as Specified in its Charter)
_______________________________
| | | | | |
Massachusetts | 06-0513860 |
(State or Other Jurisdiction of | (I. R. S. Employer Identification No.) |
Incorporation or Organization) | |
2225 W. Chandler Blvd., Chandler, Arizona 85224-6155
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (480) 917-6000
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, | par value $1.00 per share | ROG | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | |
Large accelerated filer | ☒ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
The number of shares outstanding of the registrant’s capital stock as of April 25, 2022 was 18,803,405.
ROGERS CORPORATION
FORM 10-Q
March 31, 2022
| | | | | | | | | | | |
TABLE OF CONTENTS |
Part I – Financial Information |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Part II – Other Information |
| | | |
| | | |
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Refer to “Forward-Looking Statements” in Item 2, Management’s Discussion and Analysis of Results of Operations and Financial Position for additional information.
Part I – Financial Information
Item 1. Financial Statements
ROGERS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars and shares in thousands, except per share amounts)
| | | | | | | | | | | | | | | |
| Three Months Ended | | |
| March 31, 2022 | | March 31, 2021 | | | | |
Net sales | $ | 248,266 | | | $ | 229,265 | | | | | |
Cost of sales | 162,872 | | | 139,766 | | | | | |
Gross margin | 85,394 | | | 89,499 | | | | | |
| | | | | | | |
Selling, general and administrative expenses | 57,705 | | | 42,413 | | | | | |
Research and development expenses | 8,260 | | | 7,172 | | | | | |
Restructuring and impairment charges | 69 | | | 1,506 | | | | | |
Other operating (income) expense, net | (531) | | | 1,215 | | | | | |
Operating income | 19,891 | | | 37,193 | | | | | |
| | | | | | | |
Equity income in unconsolidated joint ventures | 1,275 | | | 2,181 | | | | | |
| | | | | | | |
Other income (expense), net | 267 | | | 2,968 | | | | | |
Interest expense, net | (1,069) | | | (607) | | | | | |
Income before income tax expense | 20,364 | | | 41,735 | | | | | |
Income tax expense | 3,764 | | | 10,517 | | | | | |
Net income | $ | 16,600 | | | $ | 31,218 | | | | | |
| | | | | | | |
Basic earnings per share | $ | 0.88 | | | $ | 1.67 | | | | | |
Diluted earnings per share | $ | 0.87 | | | $ | 1.66 | | | | | |
| | | | | | | |
Shares used in computing: | | | | | | | |
Basic earnings per share | 18,780 | | | 18,712 | | | | | |
Diluted earnings per share | 18,999 | | | 18,774 | | | | | |
The accompanying notes are an integral part of the condensed consolidated financial statements.
3
ROGERS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(Dollars in thousands)
| | | | | | | | | | | | | | | |
| Three Months Ended | | |
| March 31, 2022 | | March 31, 2021 | | | | |
Net income | $ | 16,600 | | | $ | 31,218 | | | | | |
| | | | | | | |
Foreign currency translation adjustment | (11,757) | | | (13,259) | | | | | |
Pension and other postretirement benefits: | | | | | | | |
| | | | | | | |
| | | | | | | |
Amortization of loss, net of tax (Note 4) | 86 | | | 63 | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Other comprehensive income (loss) | (11,671) | | | (13,196) | | | | | |
Comprehensive income | $ | 4,929 | | | $ | 18,022 | | | | | |
The accompanying notes are an integral part of the condensed consolidated financial statements.
4
ROGERS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(Unaudited)
(Dollars and shares in thousands, except par value)
| | | | | | | | | | | |
| March 31, 2022 | | December 31, 2021 |
Assets | | | |
Current assets | | | |
Cash and cash equivalents | $ | 182,144 | | | $ | 232,296 | |
Accounts receivable, less allowance for credit losses of $798 and $1,223 | 173,387 | | | 163,092 | |
Contract assets | 39,177 | | | 36,610 | |
Inventories | 152,150 | | | 133,384 | |
Prepaid income taxes | 2,898 | | | 1,921 | |
Asbestos-related insurance receivables, current portion | 3,176 | | | 3,176 | |
Other current assets | 23,597 | | | 13,586 | |
Total current assets | 576,529 | | | 584,065 | |
Property, plant and equipment, net of accumulated depreciation of $365,671 and $367,850 | 349,681 | | | 326,967 | |
Investments in unconsolidated joint ventures | 15,508 | | | 16,328 | |
Deferred income taxes | 32,521 | | | 32,671 | |
Goodwill | 364,684 | | | 370,189 | |
Other intangible assets, net of amortization | 169,977 | | | 176,353 | |
Pension assets | 5,274 | | | 5,123 | |
Asbestos-related insurance receivables, non-current portion | 59,391 | | | 59,391 | |
Other long-term assets | 19,697 | | | 27,479 | |
Total assets | $ | 1,593,262 | | | $ | 1,598,566 | |
Liabilities and Shareholders’ Equity | | | |
Current liabilities | | | |
Accounts payable | $ | 74,916 | | | $ | 64,660 | |
Accrued employee benefits and compensation | 34,382 | | | 48,196 | |
Accrued income taxes payable | 1,384 | | | 9,632 | |
Asbestos-related liabilities, current portion | 3,841 | | | 3,841 | |
Other accrued liabilities | 46,643 | | | 37,620 | |
Total current liabilities | 161,166 | | | 163,949 | |
Borrowings under revolving credit facility | 190,000 | | | 190,000 | |
Pension and other postretirement benefits liabilities | 1,638 | | | 1,618 | |
Asbestos-related liabilities, non-current portion | 64,250 | | | 64,491 | |
Non-current income tax | 8,205 | | | 7,131 | |
Deferred income taxes | 27,739 | | | 29,451 | |
Other long-term liabilities | 22,786 | | | 23,031 | |
Commitments and contingencies (Note 10 and Note 12) | | | |
Shareholders’ equity | | | |
Capital stock - $1 par value; 50,000 authorized shares; 18,803 and 18,730 shares issued and outstanding | 18,803 | | | 18,730 | |
Additional paid-in capital | 157,164 | | | 163,583 | |
Retained earnings | 998,425 | | | 981,825 | |
Accumulated other comprehensive loss | (56,914) | | | (45,243) | |
Total shareholders' equity | 1,117,478 | | | 1,118,895 | |
Total liabilities and shareholders' equity | $ | 1,593,262 | | | $ | 1,598,566 | |
The accompanying notes are an integral part of the condensed consolidated financial statements.
5
ROGERS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in thousands)
`` | | | | | | | | | | | |
| Three Months Ended |
| March 31, 2022 | | March 31, 2021 |
Operating Activities: | | | |
Net income | $ | 16,600 | | | $ | 31,218 | |
Adjustments to reconcile net income to cash provided by operating activities: | | | |
Depreciation and amortization | 10,724 | | | 10,325 | |
Equity compensation expense | 3,202 | | | 4,006 | |
Deferred income taxes | (2,013) | | | 1,570 | |
Equity in undistributed income of unconsolidated joint ventures | (1,275) | | | (2,181) | |
Dividends received from unconsolidated joint ventures | 1,509 | | | 1,754 | |
| | | |
Pension and other postretirement benefits | 29 | | | (79) | |
| | | |
(Gain) loss on sale or disposal of property, plant and equipment | (15) | | | (89) | |
| | | |
UTIS fire fixed asset and inventory write-offs | 201 | | | 1,171 | |
Provision (benefit) for credit losses | (142) | | | (345) | |
Changes in assets and liabilities: | | | |
Accounts receivable | (14,384) | | | (11,397) | |
Proceeds from insurance/government subsidies related to operations | 334 | | | — | |
Contract assets | (3,121) | | | (4,361) | |
Inventories | (19,935) | | | (6,894) | |
Pension and postretirement benefit contributions | (24) | | | (147) | |
Other current assets | (11,099) | | | (6,132) | |
Accounts payable and other accrued expenses | (4,809) | | | 17,967 | |
Other, net | 10,495 | | | 135 | |
Net cash (used in) provided by operating activities | (13,723) | | | 36,521 | |
| | | |
Investing Activities: | | | |
| | | |
Capital expenditures | (28,249) | | | (3,602) | |
| | | |
Proceeds from insurance claims | 2,262 | | | — | |
| | | |
Net cash used in investing activities | (25,987) | | | (3,602) | |
| | | |
Financing Activities: | | | |
| | | |
Repayment of debt principal and finance lease obligations | (146) | | | (21,253) | |
Payments of taxes related to net share settlement of equity awards | (10,498) | | | (2,632) | |
Proceeds from issuance of shares to employee stock purchase plan | 950 | | | 704 | |
| | | |
Net cash used in financing activities | (9,694) | | | (23,181) | |
| | | |
Effect of exchange rate fluctuations on cash | (748) | | | (2,414) | |
| | | |
Net (decrease) increase in cash and cash equivalents | (50,152) | | | 7,324 | |
Cash and cash equivalents at beginning of period | 232,296 | | | 191,785 | |
Cash and cash equivalents at end of period | $ | 182,144 | | | $ | 199,109 | |
| | | |
Supplemental Disclosures: | | | |
Accrued capital additions | $ | 14,021 | | | $ | 2,814 | |
Cash paid during the year for: | | | |
Interest, net of amounts capitalized | $ | 1,068 | | | $ | 607 | |
Income taxes | $ | 7,600 | | | $ | 9,337 | |
The accompanying notes are an integral part of the condensed consolidated financial statements.
6
ROGERS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(Unaudited)
(Dollars and shares in thousands)
| | | | | | | | | | | | | | | |
| Three Months Ended | | |
| March 31, 2022 | | March 31, 2021 | | | | |
Capital Stock | | | | | | | |
Balance, beginning of period | $ | 18,730 | | | $ | 18,677 | | | | | |
Shares issued for vested restricted stock units, net of shares withheld for taxes | 67 | | | 28 | | | | | |
Shares issued for employee stock purchase plan | 6 | | | 7 | | | | | |
| | | | | | | |
| | | | | | | |
Balance, end of period | 18,803 | | | 18,712 | | | | | |
Additional Paid-In Capital | | | | | | | |
Balance, beginning of period | 163,583 | | | 147,961 | | | | | |
Shares issued for vested restricted stock units, net of shares withheld for taxes | (10,565) | | | (2,660) | | | | | |
Shares issued for employee stock purchase plan | 944 | | | 697 | | | | | |
| | | | | | | |
Equity compensation expense | 3,202 | | | 4,006 | | | | | |
| | | | | | | |
Balance, end of period | 157,164 | | | 150,004 | | | | | |
Retained Earnings | | | | | | | |
Balance, beginning of period | 981,825 | | | 873,692 | | | | | |
Net income | 16,600 | | | 31,218 | | | | | |
Balance, end of period | 998,425 | | | 904,910 | | | | | |
Accumulated Other Comprehensive Loss | | | | | | | |
Balance, beginning of period | (45,243) | | | (19,575) | | | | | |
Other comprehensive income (loss) | (11,671) | | | (13,196) | | | | | |
Balance, end of period | (56,914) | | | (32,771) | | | | | |
Total Shareholders’ Equity | $ | 1,117,478 | | | $ | 1,040,855 | | | | | |
The accompanying notes are an integral part of the condensed consolidated financial statements.
7
ROGERS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 – Basis of Presentation
As used herein, the terms “Company,” “Rogers,” “we,” “us,” “our” and similar terms mean Rogers Corporation and its consolidated subsidiaries, unless the context indicates otherwise.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) for interim financial information. Accordingly, these statements do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for their fair presentation in accordance with GAAP. All significant intercompany balances and transactions have been eliminated.
Interim results are not necessarily indicative of results for a full year. For further information regarding our accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021. Refer to the discussion below for our restructuring activities significant accounting policy.
Note 2 – Fair Value Measurements
The accounting guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value:
•Level 1 – Quoted prices in active markets for identical assets or liabilities.
•Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
•Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
As a result of our pension termination and settlement efforts in late 2019 and the first half of 2020, we have a pension surplus investment balance, which is now accounted for as an available-for-sale investment as of June 2020. For additional information regarding this balance, refer to “Note 11 – Pension Benefits and Other Postretirement Benefits.” Available-for-sale investments measured at fair value on a recurring basis, categorized by the level of inputs used in the valuation, were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Available-for-Sale Investment at Fair Value as of March 31, 2022 |
(Dollars in thousands) | Level 1 | | Level 2 | | Level 3 | | Total |
Pension surplus investment(1) | $ | 6,278 | | | $ | — | | | $ | — | | | $ | 6,278 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Available-for-Sale Investment at Fair Value as of December 31, 2021 |
(Dollars in thousands) | Level 1 | | Level 2 | | Level 3 | | Total |
Pension surplus investment(1) | $ | 6,638 | | | $ | — | | | $ | — | | | $ | 6,638 | |
(1) This balance was invested in funds comprised of short-term cash and fixed income securities, and was recorded in the “Other current assets” and the “Other long-term assets” line items in the condensed consolidated statements of financial position as of March 31, 2022 and December 31, 2021, respectively. As of March 31, 2022 and December 31, 2021, the fair value of these investments approximated its carrying value.
From time to time we enter into various instruments that require fair value measurement, including foreign currency contracts and copper derivative contracts. Derivative instruments measured at fair value on a recurring basis, categorized by the level of inputs used in the valuation, were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Derivative Instruments at Fair Value as of March 31, 2022 |
(Dollars in thousands) | Level 1 | | Level 2 | | Level 3 | | Total(1) |
Foreign currency contracts | $ | — | | | $ | (101) | | | $ | — | | | $ | (101) | |
Copper derivative contracts | $ | — | | | $ | 1,154 | | | $ | — | | | $ | 1,154 | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Derivative Instruments at Fair Value as of December 31, 2021 |
(Dollars in thousands) | Level 1 | | Level 2 | | Level 3 | | Total(1) |
Foreign currency contracts | $ | — | | | $ | (16) | | | $ | — | | | $ | (16) | |
Copper derivative contracts | $ | — | | | $ | 1,344 | | | $ | — | | | $ | 1,344 | |
| | | | | | | |
(1) All balances were recorded in the “Other current assets” or “Other accrued liabilities” line items in the condensed consolidated statements of financial position.
For additional information on derivative contracts, refer to “Note 3 – Hedging Transactions and Derivative Financial Instruments.”
Note 3 – Hedging Transactions and Derivative Financial Instruments
We are exposed to certain risks related to our ongoing business operations. The primary risks being managed through our use of derivative instruments are foreign currency exchange rate risk and commodity pricing risk (primarily related to copper). We do not use derivative instruments for trading or speculative purposes. The valuation of derivative contracts used to manage each of these risks is described below:
•Foreign Currency – The fair value of any foreign currency option derivative is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics.
•Commodity – The fair value of copper derivatives is computed using a combination of intrinsic and time value valuation models, which are collectively a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate and volatility. The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end. The time value valuation model incorporates changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative instrument’s strike price and the remaining time to the underlying copper derivative instrument’s expiration date from the period end date.
The guidance for the accounting and disclosure of derivatives and hedging transactions requires companies to recognize all of their derivative instruments as either assets or liabilities at fair value in the condensed consolidated statements of financial position. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies for hedge accounting treatment as defined under the applicable accounting guidance. For derivative instruments that are designated and qualify for hedge accounting treatment as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) in the condensed consolidated statements of comprehensive income (loss). This gain or loss is reclassified into earnings in the same line item of the condensed consolidated statements of operations associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings.
Foreign Currency
During the three months ended March 31, 2022, we entered into U.S. dollar, euro, and Korean won forward contracts. We entered into these foreign currency forward contracts to mitigate certain global transactional exposures. These contracts do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other income (expense), net” in our condensed consolidated statements of operations in the period in which the adjustment occurred.
As of March 31, 2022, the notional values of the remaining foreign currency forward contracts were as follows:
| | | | | |
Notional Values of Foreign Currency Derivatives |
USD/CNH | $ | 16,431,974 | |
EUR/USD | € | 11,687,382 | |
KRW/USD | ₩ | 7,325,880,000 | |
| |
Commodity
As of March 31, 2022, we had 11 outstanding contracts to hedge exposure related to the purchase of copper in our AES operating segment. These contracts are held with financial institutions and are intended to offset rising copper prices and do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other income (expense), net” in our condensed consolidated statements of operations in the period in which the adjustment occurred.
As of March 31, 2022, the volume of our copper contracts outstanding was as follows:
| | | | | |
Volume of Copper Derivatives |
April 2022 - June 2022 | 168 metric tons per month |
July 2022 - September 2022 | 69 metric tons per month |
October 2022 - December 2022 | 138 metric tons per month |
| |
Effects on Financial Statements
The impacts from our derivative instruments on the statement of operations and statements of comprehensive income (loss) were as follows:
| | | | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended | | |
(Dollars in thousands) | Financial Statement Line Item | | March 31, 2022 | | March 31, 2021 | | | | |
Foreign Currency Contracts | | | | | | | | | |
Contracts not designated as hedging instruments | Other income (expense), net | | $ | (682) | | | $ | (822) | | | | | |
Copper Derivative Contracts | | | | | | | | | |
Contracts not designated as hedging instruments | Other income (expense), net | | $ | 331 | | | $ | 2,547 | | | | | |
Note 4 – Accumulated Other Comprehensive Loss
The changes in accumulated other comprehensive loss by component were as follows:
| | | | | | | | | | | | | | | | | |
(Dollars and accompanying footnotes in thousands) | Foreign Currency Translation Adjustments | | Pension and Other Postretirement Benefits(1) | | Total |
Balance as of December 31, 2021 | $ | (35,641) | | | $ | (9,602) | | | $ | (45,243) | |
Other comprehensive income (loss) before reclassifications | (11,757) | | | — | | | (11,757) | |
Amounts reclassified from accumulated other comprehensive loss | — | | | 86 | | | 86 | |
Net current-period other comprehensive income (loss) | (11,757) | | | 86 | | | (11,671) | |
Balance as of March 31, 2022 | $ | (47,398) | | | $ | (9,516) | | | $ | (56,914) | |
| | | | | |
Balance as of December 31, 2020 | $ | (10,571) | | | $ | (9,004) | | | $ | (19,575) | |
Other comprehensive income (loss) before reclassifications | (13,259) | | | — | | | (13,259) | |
Amounts reclassified from accumulated other comprehensive loss | — | | | 63 | | | 63 | |
Net current-period other comprehensive income (loss) | (13,259) | | | 63 | | | (13,196) | |
Balance as of March 31, 2021 | $ | (23,830) | | | $ | (8,941) | | | $ | (32,771) | |
(1) Net of taxes of $2,100 and $2,125 as of March 31, 2022 and December 31, 2021, respectively. Net of taxes of $1,940 and $1,951 as of March 31, 2021 and December 31, 2020, respectively.
Note 5 – Inventories
Inventories, which are valued at the lower of cost or net realizable value, consisted of the following:
| | | | | | | | | | | |
(Dollars in thousands) | March 31, 2022 | | December 31, 2021 |
Raw materials | $ | 70,684 | | | $ | 60,208 | |
Work-in-process | 39,100 | | | 29,078 | |
Finished goods | 42,366 | | | 44,098 | |
Total inventories | $ | 152,150 | | | $ | 133,384 | |
Note 6 – Goodwill and Other Intangible Assets
Goodwill
The changes in the net carrying amount of goodwill by operating segment were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
(Dollars in thousands) | Advanced Electronics Solutions | | Elastomeric Material Solutions | | Other | | Total |
December 31, 2021 | $ | 119,567 | | | $ | 248,398 | | | $ | 2,224 | | | $ | 370,189 | |
Purchase accounting adjustment | — | | | (925) | | | — | | | (925) | |
| | | | | | | |
Foreign currency translation adjustment | (1,446) | | | (3,134) | | | — | | | $ | (4,580) | |
March 31, 2022 | $ | 118,121 | | | $ | 244,339 | | | $ | 2,224 | | | $ | 364,684 | |
Other Intangible Assets
The gross and net carrying amounts, as well as the accumulated amortization of other intangible assets were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2022 | | December 31, 2021 |
(Dollars in thousands) | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount |
Customer relationships | $ | 196,426 | | | $ | 79,822 | | | $ | 116,604 | | | $ | 198,095 | | | $ | 77,870 | | | $ | 120,225 | |
Technology | 87,609 | | | 55,885 | | | 31,724 | | | 88,445 | | | 54,900 | | | 33,545 | |
Trademarks and trade names | 25,130 | | | 9,243 | | | 15,887 | | | 25,504 | | | 8,968 | | | 16,536 | |
Covenants not to compete | 2,656 | | | 1,289 | | | 1,367 | | | 2,693 | | | 1,137 | | | 1,556 | |
Total definite-lived other intangible assets | 311,821 | | | 146,239 | | | 165,582 | | | 314,737 | | | 142,875 | | | 171,862 | |
Indefinite-lived other intangible asset | 4,395 | | | — | | | 4,395 | | | 4,491 | | | — | | | 4,491 | |
Total other intangible assets | $ | 316,216 | | | $ | 146,239 | | | $ | 169,977 | | | $ | 319,228 | | | $ | 142,875 | | | $ | 176,353 | |
In the table above, gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations.
Amortization expense was $4.3 million and $3.1 million for the three months ended March 31, 2022 and 2021, respectively. The estimated future amortization expense is $12.6 million for the remainder of 2022 and $15.8 million, $14.4 million, $12.6 million and $12.0 million for 2023, 2024, 2025 and 2026, respectively.
The weighted average amortization period as of March 31, 2022, by definite-lived other intangible asset class, was as follows:
| | | | | | | | |
Definite-Lived Other Intangible Asset Class | | Weighted Average Remaining Amortization Period |
Customer relationships | | 8.0 years |
Technology | | 3.6 years |
Trademarks and trade names | | 2.2 years |
Covenants not to compete | | 1.2 years |
Total definite-lived other intangible assets | | 6.6 years |
Note 7 – Earnings Per Share
Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding.
The following table sets forth the computation of basic and diluted earnings per share:
| | | | | | | | | | | | | | | |
(Dollars and shares in thousands, except per share amounts) | Three Months Ended | | |
March 31, 2022 | | March 31, 2021 | | | | |
Numerator: | | | | | | | |
Net income | $ | 16,600 | | | $ | 31,218 | | | | | |
Denominator: | | | | | | | |
Weighted-average shares outstanding - basic | 18,780 | | | 18,712 | | | | | |
Effect of dilutive shares | 219 | | | 62 | | | | | |
Weighted-average shares outstanding - diluted | 18,999 | | | 18,774 | | | | | |
Basic earnings per share | $ | 0.88 | | | $ | 1.67 | | | | | |
Diluted earnings per share | $ | 0.87 | | | $ | 1.66 | | | | | |
Dilutive shares are calculated using the treasury stock method and primarily include unvested restricted stock units. Anti-dilutive shares are excluded from the calculation of diluted shares and diluted earnings per share. For the three months ended March 31, 2022 and 2021, 32,500 shares and 44,792 shares were excluded, respectively.
Note 8 – Capital Stock and Equity Compensation
Equity Compensation
Performance-Based Restricted Stock Units
As of March 31, 2022, we had performance-based restricted stock units from 2022, 2021 and 2020 outstanding. These awards generally cliff vest at the end of a three-year measurement period. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed during the measurement period, except as noted below in Chief Executive Officer’s 2021 Equity Award Grants. Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures.
The outstanding awards have one measurement criterion: the three-year total shareholder return (TSR) on our capital stock as compared to that of a specified group of peer companies. The TSR measurement criterion of the awards is considered a market condition. As such, the fair value of this measurement criterion was determined on the grant date using a Monte Carlo simulation valuation model. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period with no changes for final projected payout of the awards. We account for forfeitures as they occur.
The following table sets forth the assumptions used in the Monte Carlo calculation for each material award granted in 2021:
| | | | | |
| February 10, 2021 |
Expected volatility | 51.0% |
Expected term (in years) | 2.9 |
Risk-free interest rate | 0.18% |
Expected volatility – In determining expected volatility, we have considered a number of factors, including historical volatility.
Expected term – We use the vesting period of the award to determine the expected term assumption for the Monte Carlo simulation valuation model.
Risk-free interest rate – We use an implied “spot rate” yield on U.S. Treasury Constant Maturity rates as of the grant date for our assumption of the risk-free interest rate.
Expected dividend yield – We do not currently pay dividends on our capital stock; therefore, a dividend yield of 0% was used in the Monte Carlo simulation valuation model.
A summary of activity of the outstanding performance-based restricted stock units for the three months ended March 31, 2022 is presented below:
| | | | | |
| Performance-Based Restricted Stock Units |
Awards outstanding as of December 31, 2021 | 114,554 | |
Awards granted | 26,819 | |
Stock issued | (60,053) | |
Awards cancelled | (465) | |
Awards outstanding as of March 31, 2022 | 80,855 | |
We recognized $1.1 million and $2.1 million of compensation expense for performance-based restricted stock units for the three months ended March 31, 2022 and 2021, respectively.
Time-Based Restricted Stock Units
As of March 31, 2022, we had time-based restricted stock unit awards from 2022, 2021, 2020 and 2019 outstanding. The outstanding awards all ratably vest on the first, second and third anniversaries of the original grant date. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed subsequent to the last grant anniversary date, except as noted below in Chief Executive Officer’s 2021 Equity Award Grants. Each time-based restricted stock unit represents a right to receive one share of Rogers’ capital stock at the end of the vesting period. The fair value of the award is determined by the market value of the underlying stock price at the grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period. We account for forfeitures as they occur.
A summary of activity of the outstanding time-based restricted stock units for the three months ended March 31, 2022 is presented below:
| | | | | |
| Time-Based Restricted Stock Units |
Awards outstanding as of December 31, 2021 | 96,989 | |
Awards granted | 62,050 | |
Stock issued | (44,884) | |
Awards cancelled | (621) | |
Awards outstanding as of March 31, 2022 | 113,534 | |
We recognized $2.1 million and $1.8 million of compensation expense for time-based restricted stock units for the three months ended March 31, 2022 and 2021, respectively.
Chief Executive Officer’s 2021 Equity Award Grants
The terms of the performance-based and time-based restricted stock unit awards granted to our Chief Executive Officer (CEO), Bruce Hoechner, in February 2021 were modified from the standard language provisions from prior year awards to allow for accelerated vesting of the full awards provided certain criteria are met. Accounting Standards Codification (ASC) Topic 718: Compensation—Stock Compensation requires companies that allow for accelerated vesting of employees’ unvested equity upon retirement to recognize the expense from the date of grant to the date the employee becomes eligible to retire – regardless of whether or not the employee actually retires when he or she is eligible to retire. As a result, the $4.0 million of expense in 2021 related to the awards granted on February 10, 2021 to our CEO, which provide for immediate vesting upon retirement, were expensed from the date of the grant, February 10, 2021, through his retirement eligibility date, November 9, 2021.
Deferred Stock Units
We grant deferred stock units to non-management directors. These awards are fully vested on the date of grant and the related shares are generally issued on the 13-month anniversary of the grant date unless the individual elects to defer the receipt of those shares. Each deferred stock unit results in the issuance of one share of Rogers’ capital stock. The grant of deferred stock units is typically done annually during the second quarter of each year. The fair value of the award is determined by the market value of the underlying stock price at the grant date.
A summary of activity of the outstanding deferred stock units for the three months ended March 31, 2022 is presented below:
| | | | | |
| Deferred Stock Units |
Awards outstanding as of December 31, 2021 | 9,500 | |
Awards granted | — | |
Stock issued | (1,000) | |
Awards outstanding as of March 31, 2022 | 8,500 | |
We recognized no compensation expense for deferred stock units for the three months ended March 31, 2022 and 2021, respectively.
Note 9 – Debt
On October 16, 2020, we entered into the Fourth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A, as administrative agent, and the lenders party thereto (the Fourth Amended Credit Agreement). The Fourth Amended Credit Agreement amends and restates the Third Amended Credit Agreement, and provides for a revolving credit facility with up to a $450.0 million borrowing capacity, with sublimits for multicurrency borrowings, letters of credit and swing-line notes, in addition to a $175.0 million accordion feature. Borrowings may be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Fourth Amended Credit Agreement). The Fourth Amended Credit Agreement extends the maturity, the date on which all amounts borrowed or outstanding under the Fourth Amended Credit Agreement are due, from February 17, 2022 to March 31, 2024.
All obligations under the Fourth Amended Credit Agreement are guaranteed by each of our existing and future material domestic subsidiaries, as defined in the Fourth Amended Credit Agreement (the Guarantors). The obligations are also secured by a Fourth Amended and Restated Pledge and Security Agreement, dated as of October 16, 2020, entered into by us and the Guarantors which grants to the administrative agent, for the benefit of the lenders, a security interest, subject to certain exceptions, in substantially all of our and the Guarantors’ non-real estate assets. These assets include, but are not limited to, receivables, equipment, intellectual property, inventory, and stock in certain subsidiaries.
On March 5, 2021, the U.K. Financial Conduct Authority (“FCA”) publicly announced that immediately after December 31, 2021, publication of most Euro, Swiss Franc, Japanese Yen and Pound Sterling Libor settings will permanently cease. On October 15, 2021, Rogers Corporation and JPMorgan Chase Bank, N.A. entered into an amendment (Amendment No 1) to the Fourth Amended Credit Agreement to adopt a new benchmark interest rate to replace the discontinued Libor reference rates.
Borrowings under the Fourth Amended Credit Agreement can be made as alternate base rate loans, euro-currency loans, or RFR loans. Alternate base rate loans bear interest at a base reference rate plus a spread of 62.5 to 100.0 basis points, depending on our leverage ratio. The base reference rate is the greatest of (a) the prime rate in effect on such day, (b) the NYFRB rate in effect on such day plus ½ of 1%, and (c) the adjusted LIBOR for a one month interest period in dollars on such day (or if such day is not a business day, the immediately preceding business day) plus 1%. Euro-currency loans bear interest based on adjusted LIBOR plus a spread of 162.5 to 200.0 basis points, depending on our leverage ratio. RFR loans bears interest based upon the Sterling Overnight Index Average (SONIA) plus 0.0326% plus a spread of 162.5 to 200.0 basis points. Based on our leverage ratio as of December 31, 2021, the spread was 162.5 basis points.
In addition to interest payable on the principal amount of indebtedness outstanding, we incur an annual fee of 25 to 35 basis points (based upon our leverage ratio), paid quarterly, of the unused amount of the lenders’ commitments under the Fourth Amended Credit Agreement.
The Fourth Amended Credit Agreement contains customary representations and warranties, covenants, mandatory prepayments and events of default under which our payment obligations may be accelerated. If an event of default occurs, the lenders may, among other things, terminate their commitments and declare all outstanding borrowings to be immediately due and payable together with accrued interest and fees. The financial covenants include requirements to maintain (1) a total net leverage ratio of no more than 3.25 to 1.00, subject to a one-time election to increase the maximum total net leverage ratio to 3.50 to 1.00 for one fiscal year in connection with a permitted acquisition, and (2) an interest coverage ratio of no less than 3.00 to 1.00. We are permitted to net up to $50.0 million of unrestricted domestic cash and cash equivalents against indebtedness in the calculation of the total net leverage ratio.
The Fourth Amended Credit Agreement generally permits us to pay cash dividends to our shareholders, provided that (i) no default or event of default has occurred and is continuing or would result from the dividend payment and (ii) our total net leverage ratio does not exceed 2.75 to 1.00. If our total net leverage ratio exceeds 2.75 to 1.00, we may nonetheless make up to $20.0 million in restricted payments, including cash dividends, during the fiscal year, provided that no default or event of
default has occurred and is continuing or would result from the payments. Our total net leverage ratio did not exceed 2.75 to 1.00 as of March 31, 2022.
We did not borrow anything under the Fourth Amended Credit Agreement for the three months ended March 31, 2022, and 2021. We are not required to make any quarterly principal payments under the Fourth Amended Credit Agreement. We made no payments for the three months ended March 31, 2022 and $21.0 million of discretionary principal payments on our revolving credit facility for the three months ended March 31, 2021, respectively.
We had $190.0 million outstanding borrowings under our revolving credit facility as of March 31, 2022, and $190.0 million as of December 31, 2021. We had $1.4 million and $1.6 million of outstanding line of credit issuance costs as of March 31, 2022 and December 31, 2021, respectively, which will be amortized over the life of the Fourth Amended Credit Agreement.
Note 10 - Leases
Amortization expense related to our finance lease right-of-use assets, which is primarily included in the “Cost of sales” line item of the condensed consolidated statements of operations, was immaterial for each of the three-month periods ended March 31, 2022 and 2021. Interest expense related to our finance lease obligations, which is included in the “Interest expense, net” line item of the condensed consolidated statements of operations, was immaterial for each of the three-month periods ended March 31, 2022 and 2021. Payments made on the principal portion of our finance lease obligations were immaterial for each of the three- and nine-month periods ended March 31, 2022 and 2021, excluding the $5.0 million net cash payment to exercise the Eschenbach, Germany manufacturing facility purchase option.
We have operating leases primarily related to building space and vehicles. Renewal options are included in the lease term to the extent we are reasonably certain to exercise the option. The exercise of lease renewal options is at our sole discretion. We account for lease components separately from non-lease components. The incremental borrowing rate represents our ability to borrow on a collateralized basis over a similar lease term.
Our expenses and payments for operating leases were as follows:
| | | | | | | | | | | | | | | |
| Three Months Ended | | |
(Dollars in thousands) | March 31, 2022 | | March 31, 2021 | | | | |
Operating leases expense | $ | 692 | | | $ | 681 | | | | | |
Short-term leases expense | $ | 122 | | | $ | 74 | | | | | |
Payments on operating lease obligations | $ | 869 | | | $ | 670 | | | | | |
Our assets and liabilities balances related to finance and operating leases reflected in the condensed consolidated statements of financial position were as follows: | | | | | | | | | | | | | | | | | |
(Dollars in thousands) | Location in Statements of Financial Position | | March 31, 2022 | | December 31, 2021 |
Finance lease right-of-use assets | Property, plant and equipment, net | | $ | 320 | | | $ | 389 | |
Operating lease right-of-use assets | Other long-term assets | | $ | 17,007 | | | $ | 17,161 | |
| | | | | |
Finance lease obligations, current portion | Other accrued liabilities | | $ | 192 | | | $ | 198 | |
Finance lease obligations, non-current portion | Other long-term liabilities | | $ | 68 | | | $ | 209 | |
Total finance lease obligations | | | $ | 260 | | | $ | 407 | |
| | | | | |
Operating lease obligations, current portion | Other accrued liabilities | | $ | 2,723 | | | $ | 2,810 | |
Operating lease obligations, non-current portion | Other long-term liabilities | | $ | 14,155 | | | $ | 14,965 | |
Total operating lease obligations | | | $ | 16,878 | | | $ | 17,775 | |
Net Future Minimum Lease Payments
The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of March 31, 2022:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Finance | | Operating |
(Dollars in thousands) | Leases Signed | | Less: Leases Not Yet Commenced | | Leases in Effect | | Leases Signed | | Less: Leases Not Yet Commenced | | Leases in Effect |
2022 | 314 | | | (259) | | | 55 | | | 2,562 | | | (53) | | | 2,509 | |
2023 | 594 | | | (395) | | | 199 | | | 2,691 | | | (76) | | | 2,615 | |
2024 | 404 | | | (395) | | | 9 | | | 1,659 | | | (71) | | | 1,588 | |
2025 | 404 | | | (395) | | | 9 | | | 1,351 | | | (41) | | | 1,310 | |
2026 | 402 | | | (395) | | | 7 | | | 1,336 | | | (9) | | | 1,327 | |
Thereafter | 293 | | | (293) | | | — | | | 11,263 | | | (4) | | | 11,259 | |
Total lease payments | 2,411 | | | (2,132) | | | 279 | | | 20,862 | | | (254) | | | 20,608 | |
Less: Interest | (146) | | | 127 | | | (19) | | | (3,742) | | | 12 | | | (3,730) | |
Present Value of Net Future Minimum Lease Payments | 2,265 | | | (2,005) | | | 260 | | | 17,120 | | | (242) | | | 16,878 | |
The following table includes information regarding the lease term and discount rates utilized in the calculation of the present value of net future minimum lease payments:
| | | | | | | | | | | |
| Finance Leases | | Operating Leases |
Weighted Average Remaining Lease Term | 1.9 years | | 11.0 years |
Weighted Average Discount Rate | 3.78% | | 3.61% |
Subsequent Event - Lease Termination
In April 2022, we successfully negotiated the termination of lease signed for the facility in South Korea, which went into effect in October 2021, in exchange for an approximately $0.4 million settlement fee. The termination of this lease reduces our operating lease right-of-use assets and lease liabilities by approximately $9.2 million each.
Note 11 – Pension Benefits and Other Postretirement Benefits
Pension and Other Postretirement Benefit Plans
As of March 31, 2022, we had one qualified noncontributory defined benefit pension plan, the Rogers Corporation Employees’ Pension Plan (the Union Plan), which was frozen and ceased accruing benefits in 2013.
Additionally, we sponsor other postretirement benefit plans, including multiple fully insured or self-funded medical plans and life insurance plans for certain retirees. The measurement date for all plans is December 31st for each respective plan year.
Pension Termination Surplus Funds
On October 17, 2019, our Chief Executive Officer approved the termination of the Rogers Corporation Defined Benefit Pension Plan (following its merger with the Hourly Employees Pension Plan of Arlon LLC, Microwave Material and Silicone Technologies Divisions, Bear, Delaware (collectively, the Merged Plan)). We provided participants of the Merged Plan an option to elect either a lump sum distribution or an annuity. A group annuity contract was purchased with an insurance company for all participants who did not elect a lump sum distribution. The insurance company became responsible for administering and paying pension benefit payments effective January 1, 2020.
Upon completion of the pension termination and settlement processes for the Merged Plan, we had a $9.7 million remaining pension surplus investment balance. In July 2020 and December 2021, we transferred $9.2 million of the pension surplus investment balance to a suspense account held within a trust for the Rogers Employee Savings and Investment Plan (RESIP), a 401(k) plan for domestic employees. In December 2021, we transferred the remaining pension investment balance not initially transferred, to the RESIP trust suspense account. The investment balance not transferred to the trust suspense account will be used to pay any final plan expenses, after which the remainder of these funds will be moved to the RESIP trust suspense account. The funds in the RESIP trust suspense account have been, and will continue to be, used to fund certain employer contributions. As of March 31, 2022, the remaining pension surplus investment balance was approximately $6.3 million.
Components of Net Periodic Benefit (Credit) Cost
The components of net periodic benefit (credit) cost were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits | | Other Postretirement Benefits |
| Three Months Ended | | | | Three Months Ended | | |
| March 31, | | | | March 31, | | |
(Dollars in thousands) | 2022 | | 2021 | | | | | | 2022 | | 2021 | | | | |
Service cost | $ | — | | | $ | — | | | | | | | $ | 10 | | | $ | 15 | | | | | |
Interest cost | 191 | | | 184 | | | | | | | 8 | | | 6 | | | | | |
Expected return of plan assets | (340) | | | (390) | | | | | | | — | | | — | | | | | |
Amortization of prior service credit | — | | | — | | | | | | | — | | | (24) | | | | | |
Amortization of net loss | 111 | | | 98 | | | | | | | — | | | — | | | | | |
| | | | | | | | | | | | | | | |
Net periodic benefit (credit) cost | $ | (38) | | | $ | (108) | | | | | | | $ | 18 | | | $ | (3) | | | | | |
Employer Contributions
There were no required or voluntary contributions made to the Union Plan or the Merged Plan for each of the three months ended March 31, 2022 and 2021. Additionally, we are not required to make additional contributions to the Union Plan for the remainder of 2022.
As there is no funding requirement for the other postretirement benefit plans, we funded these benefit payments as incurred, which were immaterial for each of the three months ended March 31, 2022 and 2021, using cash from operations.
Note 12 – Commitments and Contingencies
We are currently engaged in the following material environmental and legal proceedings:
Voluntary Corrective Action Program
Our location in Rogers, Connecticut is part of the Connecticut Voluntary Corrective Action Program (VCAP). As part of this program, we partnered with the Connecticut Department of Energy and Environmental Protection (CT DEEP) to determine the corrective actions to be taken at the site related to contamination issues. We evaluated this matter and completed internal due diligence work related to the site in the fourth quarter of 2015. Remediation activities on the site are ongoing and are recorded as reductions to the accrual as they are incurred. We incurred $1.8 million of aggregate remediation costs through March 31, 2022, and the accrual for future remediation efforts is $0.9 million.
Asbestos
Overview
We, like many other industrial companies, have been named as a defendant in a number of lawsuits filed in courts across the country by persons alleging personal injury from exposure to products containing asbestos. We have never mined, milled, manufactured or marketed asbestos; rather, we made and provided to industrial users a limited number of products that contained encapsulated asbestos, but we stopped manufacturing these products in the late 1980s. Most of the claims filed against us involve numerous defendants, sometimes as many as several hundred.
The following table summarizes the change in number of asbestos claims outstanding for the three months ended March 31, 2022:
| | | | | |
| Asbestos Claims |
Claims outstanding as of January 1 | 543 | |
New claims filed | 48 | |
Pending claims concluded(1) | (30) | |
Claims outstanding as of March 31, 2022 | 561 | |
(1) For the three months ended March 31, 2022, 26 claims were dismissed and 4 claims were settled. Settlements totaled approximately $0.7 million for the three months ended March 31, 2022.
Impact on Financial Statements
We recognize a liability for asbestos-related contingencies that are probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos-related matters, we record asbestos-related insurance receivables that are deemed probable.
The liability projection period covers all current and future indemnity and defense costs through 2064, which represents the expected end of our asbestos liability exposure with no further ongoing claims expected beyond that date. This conclusion was based on our history and experience with the claims data, the diminished volatility and consistency of observable claims data, the period of time that has elapsed since we stopped manufacturing products that contained encapsulated asbestos and an expected downward trend in claims due to the average age of our claimants, which is approaching the average life expectancy.
To date, the indemnity and defense costs of our asbestos-related product liability litigation have been substantially covered by insurance. Although we have exhausted coverage under some of our insurance policies, we believe that we have applicable primary, excess and/or umbrella coverage for claims arising with respect to most of the years during which we manufactured and marketed asbestos-containing products. In addition, we have entered into a cost sharing agreement with most of our primary, excess and umbrella insurance carriers to facilitate the ongoing administration and payment of claims covered by the carriers. The cost sharing agreement may be terminated by any party, but will continue until a party elects to terminate it. As of the filing date for this report, the agreement has not been terminated, and no carrier had informed us it intended to terminate the agreement. We expect to continue to exhaust individual primary, excess and umbrella coverages over time, and there is no assurance that such exhaustion will not accelerate due to additional claims, damages and settlements or that coverage will be available as expected. We are responsible for uninsured indemnity and defense costs, and we incurred an immaterial amount of expenses for each of the three-month periods ended March 31, 2022 and 2021, respectively, related to such costs.
The amounts recorded for the asbestos-related liability and the related insurance receivables are based on facts known at the time and a number of assumptions. However, projecting future events, such as the number of new claims to be filed each year, the average cost of disposing of such claims, the length of time it takes to dispose of such claims, coverage issues among insurers and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual liability and insurance recoveries for us to be higher or lower than those projected or recorded.
Changes recorded in the estimated liability and estimated insurance recovery based on projections of asbestos litigation and corresponding insurance coverage, result in the recognition of expense or income.
Our projected asbestos-related liabilities and insurance receivables were as follows:
| | | | | | | | | | | |
(Dollars in thousands) | March 31, 2022 | | December 31, 2021 |
Asbestos-related liabilities | $ | 68,091 | | | $ | 68,332 | |
Asbestos-related insurance receivables | $ | 62,567 | | | $ | 62,567 | |
General
In addition to the above issues, the nature and scope of our business brings us in regular contact with the general public and a variety of businesses and government agencies. Such activities inherently subject us to the possibility of litigation, including environmental and product liability matters that are defended and handled in the ordinary course of business. We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation will have a material adverse impact on our results of operations, financial position or cash flows.
Note 13 – Income Taxes
Our effective income tax rate was 18.5% and 25.2% for the three months ended March 31, 2022 and 2021, respectively. The decrease from the first quarter of 2021 was primarily due to the beneficial impact of a decrease in current quarter accruals of reserves for uncertain tax positions, as well as the increase in the windfall tax benefits associated with stock compensation.
The total amount of unrecognized tax benefits as of March 31, 2022 was $7.0 million, of which $6.4 million would affect our effective tax rate if recognized. Additionally, the balance of unrecognized tax benefits as of March 31, 2022 also included $0.6 million of tax benefits that, if recognized, would result in adjustments to other tax accounts, primarily deferred taxes.
We recognize interest and penalties related to unrecognized tax benefits through income tax expense. As of March 31, 2022, we had $1.2 million accrued for the payment of interest.
We are subject to taxation in the U.S. and various state and foreign jurisdictions. Our tax years from 2018 through 2022 are subject to examination by the tax authorities. With few exceptions, we are no longer subject to U.S. federal, state, local and foreign examinations by tax authorities for the years before 2018.
Note 14 – Operating Segment Information
Our reporting structure is comprised of the following strategic operating segments: AES and EMS. The remaining operations, which represent our non-core businesses, are reported in the Other operating segment.
Our AES operating segment designs, develops, manufactures and sells circuit materials, ceramic substrate materials, busbars and cooling solutions for applications in electric and hybrid electric vehicles (EV/HEV), wireless infrastructure (i.e., power amplifiers, antennas and small cells), automotive (i.e., advanced driver assistance systems (ADAS), telematics and thermal solutions), aerospace and defense (i.e., antenna systems, communication systems and phased array radar systems), mass transit, clean energy (i.e., variable frequency drives, renewable energy), connected devices (i.e., mobile internet devices and thermal solutions) and wired infrastructure (i.e., computing and IP infrastructure) markets.
Our EMS operating segment designs, develops, manufactures and sells engineered material solutions for a wide variety of applications and markets. These include polyurethane and silicone materials used in cushioning, gasketing and sealing, and vibration management applications for general industrial, portable electronics, automotive, EV/HEV, mass transit, aerospace and defense, footwear and impact mitigation and printing markets; customized silicones used in flex heater and semiconductor thermal applications for general industrial, portable electronics, automotive, EV/HEV, mass transit, aerospace and defense and medical markets; polytetrafluoroethylene and ultra-high molecular weight polyethylene materials used in wire and cable protection, electrical insulation, conduction and shielding, hose and belt protection, vibration management, cushioning, gasketing and sealing, and venting applications for general industrial, automotive, EV/HEV and aerospace and defense markets.
Our Other operating segment consists of elastomer components for applications in general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets. We sell our elastomer components under our ENDUR® trade name and our floats under our NITROPHYL® trade name.
The following table presents a disaggregation of revenue from contracts with customers and other pertinent financial information, for the periods indicated; inter-segment sales have been eliminated from the net sales data:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
(Dollars in thousands) | | Advanced Electronics Solutions | | Elastomeric Material Solutions | | Other | | Total |
Three Months Ended March 31, 2022 | | | | | | | | |
Net sales - recognized over time | | $ | 70,486 | | | |